Blue Horseshoe Stocks: FRO, OPK, WLGC & More

Frontline, Ltd. FRO

At the beginning of this month when we first began looking at FRO, the stock was trading at a low of 1.33. It took barely a week for the stock to start inching its way up, and it has continued to do so up to the present.

By the time we re-flagged it in Friday’s morning report, it had already cracked the $2.00-mark, and we did mention that the level of momentum was primed to allow for further opportunities.

This morning FRO continues to push the envelope, setting a new high in premarket trading action. This morning’s top figure of 2.64 puts us just slightly short of double-bagger status, having shown us an increase of 98% from the lows we observed the week before last.

It can be argued that the bolstering of activity seen on FRO (and other shipping plays) is due to the continuing fall of oil prices which translates to savings at the pump.


Opko Health, Inc. OPK

OPK is catching our attention in the premarket as well, as a result of an agreement announced this morning with pharma-giant Pfizer to develop and commercialize one of Opko’s highly promising products which combats Growth Hormone deficiency. Peruse the following PR to find out more; the development certainly lands OPK a spot on our watchlist to kick off the week.

In instances like these where a play is sent through the roof on substantial news, we look for the resulting profit-taking to pull the stock back, where we wait to take advantage of a possible dip-and-rip scenario.

OPKO Health, Inc. (OPK) and Pfizer Inc. (PFE) announced today that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD)… hGH-CTP has the potential to reduce the required dosing frequency of human growth hormone to a single weekly injection from the current standard of one injection per day. >> FULL PR


WordLogic Corp. WLGC

Speaking of significant news, WLGC forces its way into our vernacular this morning on the heels of the announcement that the company will be teaming up with energy-leviathan General Electric (GE) in order to “monetize specific patented intellectual property in General Electric’s portfolio.”

With such a high-profile bedfellow, WLGC will instantly gain new recognition, and it will be very interesting to see how that translates to the chart.


Notable Gainers from Friday’s Extended Watchlist

Oncothyreon, Inc. ONTYRange: 1.69-2.05   Gain: 21%

Organovo Holdings, Inc. ONVORange: 5.82-6.50  Gain: 11%


Extended Watchlist:
TLM, SN, BLRX, KEG, HGSH, CPST

Blue Horseshoe Stocks: ODP Update, FRO & More

Frontline, Ltd. FRO

The last time we mentioned FRO was early this month, at which time the stock was trading at a low of 1.33. It has been ramping its way up over the past few sessions, making higher highs and higher lows, and we wanted to flag it once again this morning as it is trading up significantly in the premarket.

This morning’s high of 2.15 represents an increase of 61% over the 1.33-low that we observed as recently as Monday. With the heavy early-morning momentum we’re seeing we’ll want to follow along with this play closely today and into next week.



Talisman Energy, Inc. TLM

We’ll keep an eye on TLM today as well based on some heavy premarket activity and the fact that the stock is coming up off of its 52-week lows. We’ve noticed a break on the chart due to a gapdown from around 5.60 to 4.80, and with the stock currently trading in the 4.40’s, we should be on the lookout for it to possibly make a run at filling that gap.


ChemoCentryx, Inc. CCXI

Also popping up on our morning scan is CCXI, which is currently trading feverishly in the premarket on the heels of a PR early this morning regarding positive top line results on one of its products currently in testing.

With the stock up over 100% in early trading, we’re going to be on the lookout for massive profit-taking to potentially drive the price back down where it may set us up to take advantage of a dip-and-rip opportunity.

MOUNTAIN VIEW, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (CCXI), a clinical-stage biopharmaceutical company focused on autoimmune diseases, inflammatory disorders and cancer, today announced positive top-line 52-week data from its Phase II clinical trial in diabetic nephropathy with CCX140, an inhibitor of the chemokine receptor known as CCR2. >> FULL PR


Office Depot, Inc. ODP

ODP was a good call for yesterday’s session, as it made a solid 8% move on news that a large activist investor took up a significant position in Office Depot while raising its existing stake in Staple stock to 10% total ownership. It is fueling speculation that there could be pressure for a merger between the two, so this is definitely a story we’ll continuously track going forward.


Extended Watchlist:
ONVO, ONTY, DENN, FCEL, UBIQ

EWSI, FREE, PLUG, IDRA, DSCO & Extended Watchlist

E-Waste Systems, Inc.  EWSI
Following Friday’s newsletter, EWSI opened at its low of day at .043, and would go on to close at its high of day at .05, marking an increase of 16% This comes after we pointed out the stock coming off of a recent bottom, and with a bullish close like we saw on Friday, we are going to be watching this one to make higher lows and higher highs to confirm the current uptrend.

We were clued into re-alerting EWSI on Friday as a result of a good chart setup on both the RSI and the MACD. With no morning gap-up, Friday’s 16% move was purely realized gain.

We have witnessed EWSI run to ten cents in the past, so we know for a fact that it is capable of much larger gains. Indicators seem to point to the current push spanning multiple sessions, leaving it high on our watchlists as we begin a new trading week.


FreeSeas, Inc. FREE
Over the course of a few weeks since we alerted FREE for the first time on 09/10, we have seen FREE go on a mammoth run from .2213 all the way up to .9287, an increase of 320%

Following that peak, the stock has pulled back to find support in the .60-.70 range, and now have it on watch for another possible leg up from these levels. The next key area of resistance from here is going to be the 200DMA at .98.


Plug Power, Inc. PLUG

We first called PLUG on 02/15 as a “potential recovery play” right after we noticed the stock hitting its 52-week lows. What we ended up seeing from PLUG was a recovery, and then some. Over the past several months, the stock not only regained the ground to where it had fallen off a cliff in early February, but the stock has continued its ascent, touching a high of .80 in early September.

As you can see, gains of nearly 600% were possible for anyone who had caught this play at or near its 52-week low on the heels of our initial alert.


Idera Pharmaceuticals, Inc. IDRA
& Discovery Laboratories, Inc. DSCO

Both of these stocks gapped up on Friday after appearing in our extended watchlist, and we still have them on our radars heading into this week.

Each stock traded large volume during Friday’s sessions, so we’re interested to see if they can build up some momentum.


Extended Watchlist:

RNN, ONVO, ONTY, CTIC, TKMR, ATOS(Huge gap down, watching for a potential bounce)